Literature DB >> 16943584

Postprandial lipemia as a risk factor for cardiovascular disease in patients with hypothyroidism.

Nedret Tanaci1, Derun Taner Ertugrul, Mustafa Sahin, Muammer Yucel, Irem Olcay, Nilgun Guvener Demirag, Alptekin Gursoy.   

Abstract

Postprandial lipoprotein metabolism is suggested to play a role in the pathogenesis of atherosclerosis. In this study, we investigated postprandial lipemia and its relationship to cardiovascular risk factors in patients with overt and subclinical hypothyroidism. Twenty-nine female patients with TSH levels greater than 5 microIU/mL and 12 euthyroid control female subjects were included in the study. Fifteen patients had subclinical hypothyroidism and 14 had overt hypothyroidism. All subjects underwent an oral lipid tolerance test. If triglyceride levels increased by 80% or more, subjects were considered postprandial lipemia positive. Control, overt hypothyroid, and subclinical hypothyroid groups were not statistically different with respect to anthropometric measurements, fasting blood C-reactive protein, uric acid, homocysteine, glucose, insulin, lipoprotein (a), apolipoprotein B levels, and homeostasis model assessment index. Fasting triglyceride levels correlated positively with TSH levels. Postprandial lipemia frequency was higher in overt hypothyroid subjects than in the control group. The subclinical hypothyroid group did not differ from the hypothyroid group with respect to postprandial lipemia frequency. In subjects with TSH levels higher than 5 microIU/mL, PPL risk was increased sevenfold. The results of this study show that postprandial triglyceride metabolism is affected in hypothyroidism.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16943584     DOI: 10.1385/ENDO:29:3:451

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  27 in total

Review 1.  Clinical review 115: effect of thyroxine therapy on serum lipoproteins in patients with mild thyroid failure: a quantitative review of the literature.

Authors:  M D Danese; P W Ladenson; C L Meinert; N R Powe
Journal:  J Clin Endocrinol Metab       Date:  2000-09       Impact factor: 5.958

2.  Myxedema and coronary artery disease--a comparative autopsy study.

Authors:  A D Steinberg
Journal:  Ann Intern Med       Date:  1968-02       Impact factor: 25.391

3.  Lipoprotein cholesterol concentrations in the plasma of human subjects as measured in the fed and fasted states.

Authors:  J S Cohn; J R McNamara; E J Schaefer
Journal:  Clin Chem       Date:  1988-12       Impact factor: 8.327

4.  Serum lipoprotein and apolipoprotein concentrations and tissue lipoprotein-lipase activity in overt and subclinical hypothyroidism: the effect of substitution therapy.

Authors:  H Lithell; J Boberg; K Hellsing; S Ljunghall; G Lundqvist; B Vessby; L Wide
Journal:  Eur J Clin Invest       Date:  1981-02       Impact factor: 4.686

5.  Thyroxine replacement therapy enhances clearance of chylomicron remnants in patients with hypothyroidism.

Authors:  M Weintraub; I Grosskopf; Y Trostanesky; G Charach; A Rubinstein; N Stern
Journal:  J Clin Endocrinol Metab       Date:  1999-07       Impact factor: 5.958

6.  Plasma total homocysteine levels in hyperthyroid and hypothyroid patients.

Authors:  B G Nedrebø; U B Ericsson; O Nygård; H Refsum; P M Ueland; A Aakvaag; S Aanderud; E A Lien
Journal:  Metabolism       Date:  1998-01       Impact factor: 8.694

7.  Serum biomarkers for cardiovascular inflammation in subclinical hypothyroidism.

Authors:  William J Hueston; Dana E King; Mark E Geesey
Journal:  Clin Endocrinol (Oxf)       Date:  2005-11       Impact factor: 3.478

8.  The effects of thyroxine replacement on the levels of serum asymmetric dimethylarginine (ADMA) and other biochemical cardiovascular risk markers in patients with subclinical hypothyroidism.

Authors:  Omer Ozcan; Erdinc Cakir; Halil Yaman; Emin Ozgur Akgul; Kivilcim Erturk; Zeynel Beyhan; Cumhur Bilgi; Mehmet Kemal Erbil
Journal:  Clin Endocrinol (Oxf)       Date:  2005-08       Impact factor: 3.478

9.  Maximal post-prandial triglyceride increase reflects post-prandial hypertriglyceridaemia and is associated with the insulin resistance syndrome.

Authors:  B G Karamanos; A C Thanopoulou; D P Roussi-Penesi
Journal:  Diabet Med       Date:  2001-01       Impact factor: 4.359

10.  Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies.

Authors:  J E Hokanson; M A Austin
Journal:  J Cardiovasc Risk       Date:  1996-04
View more
  6 in total

1.  Subclinical hypothyroidism and hyperthyroidism have opposite effects on hepatic very-low-density lipoprotein-triglyceride kinetics.

Authors:  Elisa Fabbrini; Faidon Magkos; Bruce W Patterson; Bettina Mittendorfer; Samuel Klein
Journal:  J Clin Endocrinol Metab       Date:  2012-01-11       Impact factor: 5.958

2.  Postprandial lipaemia suppresses endothelium-dependent arterial dilation in patients with hypothyroidism.

Authors:  Guang Da Xiang; Ling Wei Xiang; Hong Lin He; Lin Shuang Zhao
Journal:  Endocrine       Date:  2012-02-22       Impact factor: 3.633

3.  Decreased expression of hepatic low-density lipoprotein receptor-related protein 1 in hypothyroidism: a novel mechanism of atherogenic dyslipidemia in hypothyroidism.

Authors:  Jae Hoon Moon; Hyung Jun Kim; Hyun Min Kim; Sung Hee Choi; Soo Lim; Young Joo Park; Hak Chul Jang; Bong Soo Cha
Journal:  Thyroid       Date:  2013-08-28       Impact factor: 6.568

Review 4.  A Renewed Focus on the Association Between Thyroid Hormones and Lipid Metabolism.

Authors:  Leonidas H Duntas; Gabriela Brenta
Journal:  Front Endocrinol (Lausanne)       Date:  2018-09-03       Impact factor: 5.555

5.  Evolving data analysis of an Oral Lipid Tolerance Test toward the standard for the Oral Glucose Tolerance Test: Cross species modeling effects of AZD7687 on plasma triacylglycerol.

Authors:  Pablo Morentin Gutierrez; James Yates; Catarina Nilsson; Sue Birtles
Journal:  Pharmacol Res Perspect       Date:  2019-03-09

6.  A Population-Based Cohort Study on the Association of Hyperthyroidism With the Risk of Hyperlipidemia and the Effects of Anti-thyroid Drugs on Hepatic Gene Expression.

Authors:  Tien-Yuan Wu; Chung-Hsing Wang; Ni Tien; Cheng-Li Lin; Fang-Yi Chu; Hsiao-Yun Chang; Yun-Ping Lim
Journal:  Front Med (Lausanne)       Date:  2020-05-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.